skip to Main Content
Contact Us   480.314.3070 |

Imaging Endpoints is contributing to a new Nature publication showing that Quantitative MRI of vascular disrupting agents may aid cancer drug development.

To read the full study, visit https://www.nature.com/articles/s41598-020-71246-w.

Back To Top